Formulation Development Outsourcing Market (By Service: Preformulation, Formulation Development; By Formulation: Oral, Injectable; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

Chapter 1.  Introduction

1.1.Research Objective

1.2.Scope of the Study

1.3.Definition

Chapter 2.  Research Methodology

2.1.Research Approach

2.2.Data Sources

2.3.Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.Introduction

4.2.Market Classification and Scope

4.3.Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Therapeutic Area Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5.  COVID 19 Impact on Formulation Development Outsourcing Market

5.1.COVID-19 Landscape: Formulation Development Outsourcing Industry Impact

5.2.COVID 19 - Impact Assessment for the Industry

5.3.COVID 19 Impact: Global Major Government Policy

5.4.Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6.  Market Dynamics Analysis and Trends

6.1.Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2.Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7.  Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1.  List of Suppliers

7.1.3.2.  List of Buyers

Chapter 8.  Global Formulation Development Outsourcing Market, By Service

8.1.Formulation Development Outsourcing Market, by Service Type, 2022-2030

8.1.1. Preformulation

8.1.1.1.  Market Revenue and Forecast (2017-2030)

8.1.2. Formulation Development

8.1.2.1.  Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Formulation Development Outsourcing Market, By Formulation

9.1.Formulation Development Outsourcing Market, by Formulation, 2022-2030

9.1.1. Oral

9.1.1.1.  Market Revenue and Forecast (2017-2030)

9.1.2. Injectable

9.1.2.1.  Market Revenue and Forecast (2017-2030)

9.1.3. Topical

9.1.3.1.  Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1.  Market Revenue and Forecast (2017-2030)

Chapter 10.Global Formulation Development Outsourcing Market, By Therapeutic Area Channel

10.1.Formulation Development Outsourcing Market, by Therapeutic Area Channel, 2022-2030

10.1.1.Oncology

10.1.1.1.   Market Revenue and Forecast (2017-2030)

10.1.2.Infectious Diseases

10.1.2.1.   Market Revenue and Forecast (2017-2030)

10.1.3.Neurology

10.1.3.1.   Market Revenue and Forecast (2017-2030)

10.1.4.Hematology

10.1.4.1.   Market Revenue and Forecast (2017-2030)

10.1.5.Respiratory

10.1.5.1.   Market Revenue and Forecast (2017-2030)

10.1.6.Cardiovascular

10.1.6.1.   Market Revenue and Forecast (2017-2030)

10.1.7.Dermatology

10.1.7.1.   Market Revenue and Forecast (2017-2030)

10.1.8.Others

10.1.8.1.   Market Revenue and Forecast (2017-2030)

Chapter 11.Global Formulation Development Outsourcing Market, Regional Estimates and Trend Forecast

11.1.North America

11.1.1.Market Revenue and Forecast, by Service (2017-2030)

11.1.2.Market Revenue and Forecast, by Formulation (2017-2030)

11.1.3.Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.1.4.U.S.

11.1.4.1.   Market Revenue and Forecast, by Service (2017-2030)

11.1.4.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.1.4.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.1.5.Rest of North America

11.1.5.1.   Market Revenue and Forecast, by Service (2017-2030)

11.1.5.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.1.5.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.2.Europe

11.2.1.Market Revenue and Forecast, by Service (2017-2030)

11.2.2.Market Revenue and Forecast, by Formulation (2017-2030)

11.2.3.Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.2.4.UK

11.2.4.1.   Market Revenue and Forecast, by Service (2017-2030)

11.2.4.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.2.4.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.2.5.Germany

11.2.5.1.   Market Revenue and Forecast, by Service (2017-2030)

11.2.5.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.2.5.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.2.6.France

11.2.6.1.   Market Revenue and Forecast, by Service (2017-2030)

11.2.6.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.2.6.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.2.7.Rest of Europe

11.2.7.1.   Market Revenue and Forecast, by Service (2017-2030)

11.2.7.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.2.7.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.3.APAC

11.3.1.Market Revenue and Forecast, by Service (2017-2030)

11.3.2.Market Revenue and Forecast, by Formulation (2017-2030)

11.3.3.Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.3.4.India

11.3.4.1.   Market Revenue and Forecast, by Service (2017-2030)

11.3.4.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.3.4.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.3.5.China

11.3.5.1.   Market Revenue and Forecast, by Service (2017-2030)

11.3.5.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.3.5.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.3.6.Japan

11.3.6.1.   Market Revenue and Forecast, by Service (2017-2030)

11.3.6.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.3.6.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.3.7.Rest of APAC

11.3.7.1.   Market Revenue and Forecast, by Service (2017-2030)

11.3.7.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.3.7.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.4.MEA

11.4.1.Market Revenue and Forecast, by Service (2017-2030)

11.4.2.Market Revenue and Forecast, by Formulation (2017-2030)

11.4.3.Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.4.4.GCC

11.4.4.1.   Market Revenue and Forecast, by Service (2017-2030)

11.4.4.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.4.4.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.4.5.North Africa

11.4.5.1.   Market Revenue and Forecast, by Service (2017-2030)

11.4.5.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.4.5.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.4.6.South Africa

11.4.6.1.   Market Revenue and Forecast, by Service (2017-2030)

11.4.6.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.4.6.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.4.7.Rest of MEA

11.4.7.1.   Market Revenue and Forecast, by Service (2017-2030)

11.4.7.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.4.7.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.5.Latin America

11.5.1.Market Revenue and Forecast, by Service (2017-2030)

11.5.2.Market Revenue and Forecast, by Formulation (2017-2030)

11.5.3.Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.5.4.Brazil

11.5.4.1.   Market Revenue and Forecast, by Service (2017-2030)

11.5.4.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.5.4.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

11.5.5.Rest of LATAM

11.5.5.1.   Market Revenue and Forecast, by Service (2017-2030)

11.5.5.2.   Market Revenue and Forecast, by Formulation (2017-2030)

11.5.5.3.   Market Revenue and Forecast, by Therapeutic Area Channel (2017-2030)

Chapter 12.Company Profiles

12.1.SGS S.A.

12.1.1.Company Overview

12.1.2.Product offerings

12.1.3.Financial Performance

12.1.4.Recent Initiatives

12.2.Intertek Group plc

12.2.1.Company Overview

12.2.2.Product offerings

12.2.3.Financial Performance

12.2.4.Recent Initiatives

12.3.Recipharm

12.3.1.Company Overview

12.3.2.Product offerings

12.3.3.Financial Performance

12.3.4.Recent Initiatives

12.4.Lonza

12.4.1.Company Overview

12.4.2.Product offerings

12.4.3.Financial Performance

12.4.4.Recent Initiatives

12.5.Charles River Laboratories International, Inc.

12.5.1.Company Overview

12.5.2.Product offerings

12.5.3.Financial Performance

12.5.4.Recent Initiatives

12.6.Eurofins Scientific SE

12.6.1.Company Overview

12.6.2.Product offerings

12.6.3.Financial Performance

12.6.4.Recent Initiatives

12.7.Element

12.7.1.Company Overview

12.7.2.Product offerings

12.7.3.Financial Performance

12.7.4.Recent Initiatives

12.8.Labcorp

12.8.1.Company Overview

12.8.2.Product offerings

12.8.3.Financial Performance

12.8.4.Recent Initiatives

12.9.Thermo Fisher Scientific, Inc. (Patheon)

12.9.1.Company Overview

12.9.2.Product offerings

12.9.3.Financial Performance

12.9.4.Recent Initiatives

12.10.Catalent Inc.

12.10.1. Company Overview

12.10.2. Product offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13.Research Methodology

13.1.Primary Research

13.2.Secondary Research

13.3.Assumptions

Chapter 14.Appendix

14.1.About Us

14.2.Glossary of Terms

Report Details

  • Report Code:39253
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:June 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers